Article Information
History
- September 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Trisha P. Gupte1,
- Zahra Azizi1,
- Pik Fang Kho1,
- Jiayan Zhou1,
- Ming-Li Chen1,
- Daniel J. Panyard2,
- Rodrigo Guarischi-Sousa1,3,
- Austin T. Hilliard1,3,
- Disha Sharma1,
- Kathleen Watson4,
- Fahim Abbasi1,5,
- Philip S. Tsao1,5,
- Shoa L. Clarke1,5 and
- Themistocles L. Assimes1,5,6,*
- 1Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA
- 2Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
- 3Palo Alto Veterans Institute for Research (PAVIR), Stanford, CA, USA
- 4Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
- 5Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA
- 6Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA
- ↵*Corresponding author:
Themistocles L. Assimes, MD PhD, Palo Alto VA Hospital, 3801 Miranda Avenue, Palo Alto, CA, 94304, Email: tassimes{at}stanford.edu
Posted September 15, 2024.
A plasma proteomic signature for atherosclerotic cardiovascular disease risk prediction in the UK Biobank cohort
